Biofrontera (BFRIW) Receivables (2020 - 2025)

Biofrontera's Receivables history runs 6 years deep, the most recent figure standing at $12.1 million for Q4 2025.

• In Q4 2025, Receivables rose 13.9% year-over-year to $12.1 million; the TTM figure through Dec 2025 stood at $12.1 million (up 13.9% YoY), while the FY2025 annual figure was $12.1 million, up 13.9% from the prior year.
• Receivables was $12.1 million for Q4 2025 at Biofrontera, up from $3.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $12.4 million in Q4 2021 to a low of $2.1 million in Q3 2021.
• Historically, Receivables has averaged $6.4 million across 5 years, with a median of $5.8 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Receivables jumped 277.96% in 2021, then plunged 53.08% in 2024.
• A 5-year view of Receivables shows it stood at $12.4 million in 2021, then sank by 40.42% to $7.4 million in 2022, then gained by 7.51% to $8.0 million in 2023, then surged by 33.32% to $10.6 million in 2024, then increased by 13.9% to $12.1 million in 2025.
• The last three Receivables figures came in at $12.1 million (Q4 2025), $3.0 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.